Significant Accounting Policies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Antidilutive Securities Excluded from Earnings Per Share Calculations | The following table reflects the total potential share-based instruments outstanding at July 31, 2026 and 2025 including those that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive.
|
||||||||||||||||||||||||||||||||||||||||||||||||